Am. J. Respir. Crit. Care Med., Volume 164, Number 7, October 2001, 1154-1160

Epidemiology of Neonatal Respiratory Failure in the United States
Projections from California and New York

DEREK C. ANGUS, WALTER T. LINDE-ZWIRBLE, GILLES CLERMONT, MARTIN F. GRIFFIN, and REESE H. CLARK

Critical Care Medicine Division, Department of Anesthesiology and Critical Care Medicine, and the Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania; Health Process Management, Inc., Doylestown, Pennsylvania; Pediatrix Medical Group, Weston, Florida; and Department of Pediatrics, Duke University, Durham, North Carolina

We wanted to determine the incidence, cost, outcome, and patterns of care for neonates requiring mechanical ventilation (MV) in the United States. Using 1994 state hospital discharge data from California and New York, we conducted an observational study of all neonatal hospitalizations (n = 16,405) with MV, comparing outcomes at centers of different technological capability, and generating national projections using census and natality reports. The MV rate was 18 per 1,000 live births. Although the incidence was much higher in lower birth weight (BW) babies, one-third had normal BW. The incidence was higher in boys (20 versus 15.6 per 1,000) and in blacks (29 per 1,000). Hospital mortality was 11.1%, higher in minority groups, and associated with low BW, congenital anomalies, and major hemorrhage. Mean hospital length of stay and costs were 31.1 d and $51,700. Half of all deaths occurred at lower level centers. There are 80,000 cases per year in the United States with 8,500 deaths and total hospital costs of $4.4 billion. We conclude neonatal respiratory failure is common, expensive, and frequently fatal. There are a surprisingly large number of normal BW cases and there are large racial differences.

This article has been cited by other articles:

				C.-M. Chen, L.-F. Wang, and K.-T. Cheng Maternal Baicalin Treatment Increases Fetal Lung Surfactant Phospholipids in Rats Evid. Based Complement. Altern. Med., July 7, 2009; (2009) nep073v1. [Abstract] [Full Text] [PDF]

				L. Qian, C. Liu, W. Zhuang, Y. Guo, J. Yu, H. Chen, S. Wang, Z. Lin, S. Xia, L. Ni, et al. Neonatal Respiratory Failure: A 12-Month Clinical Epidemiologic Study From 2004 to 2005 in China Pediatrics, May 1, 2008; 121(5): e1115 - e1124. [Abstract] [Full Text] [PDF]

				R. H Steinhorn and K. N Farrow Pulmonary Hypertension in the Neonate NeoReviews, January 1, 2007; 8(1): e14 - e21. [Abstract] [Full Text] [PDF]

				T. N.K. Raju, R. D. Higgins, A. R. Stark, and K. J. Leveno Optimizing Care and Outcome for Late-Preterm (Near-Term) Infants: A Summary of the Workshop Sponsored by the National Institute of Child Health and Human Development Pediatrics, September 1, 2006; 118(3): 1207 - 1214. [Abstract] [Full Text] [PDF]

				D. C. Angus, G. Clermont, R. S. Watson, W. T. Linde-Zwirble, R. H. Clark, and M. S. Roberts Cost-Effectiveness of Inhaled Nitric Oxide in the Treatment of Neonatal Respiratory Failure in the United States Pediatrics, December 1, 2003; 112(6): 1351 - 1360. [Abstract] [Full Text] [PDF]

				J. P. Kinsella Meconium Aspiration Syndrome: Is Surfactant Lavage the Answer? Am. J. Respir. Crit. Care Med., August 15, 2003; 168(4): 413 - 414. [Full Text] [PDF]

				L. M. Nogee Abnormal Expression of Surfactant Protein C and Lung Disease Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 641 - 644. [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]